{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:06:15Z","timestamp":1785765975689,"version":"3.56.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T00:00:00Z","timestamp":1573171200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007144","name":"University of Houston","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007144","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.ajpath.2019.08.013","type":"journal-article","created":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T02:56:31Z","timestamp":1573527391000},"page":"2459-2468","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Medroxyprogesterone Acetate Prevention of Cervical Cancer through Progesterone Receptor in a Human Papillomavirus Transgenic Mouse Model"],"prefix":"10.1016","volume":"189","author":[{"given":"Seunghan","family":"Baik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiola F.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Hyuk","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2019.08.013_bib1","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nrc3728","article-title":"Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions","volume":"14","author":"Steenbergen","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ajpath.2019.08.013_bib2","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.31937","article-title":"Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods","volume":"144","author":"Ferlay","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajpath.2019.08.013_bib3","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1006\/pmed.1995.1096","article-title":"Psychological response to cervical screening","volume":"24","author":"Bell","year":"1995","journal-title":"Prev Med"},{"key":"10.1016\/j.ajpath.2019.08.013_bib4","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/sj.bjc.6603086","article-title":"Psychological effects of a low-grade abnormal cervical smear test result: anxiety and associated factors","volume":"94","author":"Gray","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ajpath.2019.08.013_bib5","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/0002-9378(91)90304-A","article-title":"Adverse psychologic consequences of positive cytologic cervical screening","volume":"165","author":"Lerman","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajpath.2019.08.013_bib6","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0090-8258(89)90170-4","article-title":"Impact of cervical intraepithelial neoplasia diagnosis and treatment on self-esteem and body image","volume":"34","author":"McDonald","year":"1989","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajpath.2019.08.013_bib7","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/nrc.2018.13","article-title":"Opportunities and challenges for human papillomavirus vaccination in cancer","volume":"18","author":"Roden","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ajpath.2019.08.013_bib8","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajpath.2019.08.013_bib9","doi-asserted-by":"crossref","first-page":"b2569","DOI":"10.1136\/bmj.b2569","article-title":"Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study","volume":"339","author":"Castle","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.ajpath.2019.08.013_bib10","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1470-2045(08)70103-7","article-title":"Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study","volume":"9","author":"McCredie","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ajpath.2019.08.013_bib11","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(02)08150-3","article-title":"Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study","volume":"359","author":"Moreno","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ajpath.2019.08.013_bib12","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0140-6736(02)08151-5","article-title":"Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study","volume":"359","author":"Munoz","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ajpath.2019.08.013_bib13","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1002\/pro.3496","article-title":"The nuclear receptor superfamily: a structural perspective","volume":"27","author":"Weikum","year":"2018","journal-title":"Protein Sci"},{"key":"10.1016\/j.ajpath.2019.08.013_bib14","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1056\/NEJMoa1013961","article-title":"Adverse health outcomes in women exposed in utero to diethylstilbestrol","volume":"365","author":"Hoover","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2019.08.013_bib15","doi-asserted-by":"crossref","first-page":"29361","DOI":"10.18632\/oncotarget.12957","article-title":"Antiestrogen use reduces risk of cervical neoplasia in breast cancer patients: a population-based study","volume":"8","author":"Hsieh","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ajpath.2019.08.013_bib16","doi-asserted-by":"crossref","first-page":"489.e1","DOI":"10.1016\/j.ajog.2009.01.030","article-title":"Depot-medroxyprogesterone acetate and combined oral contraceptive use and cervical neoplasia among women with oncogenic human papillomavirus infection","volume":"200","author":"Harris","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajpath.2019.08.013_bib17","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1073\/pnas.93.7.2930","article-title":"Chronic estrogen-induced cervical and vaginal squamous carcinogenesis in human papillomavirus type 16 transgenic mice","volume":"93","author":"Arbeit","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2019.08.013_bib18","first-page":"1267","article-title":"Sensitivity of the cervical transformation zone to estrogen-induced squamous carcinogenesis","volume":"60","author":"Elson","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2019.08.013_bib19","first-page":"4862","article-title":"Dissection of human papillomavirus E6 and E7 function in transgenic mouse models of cervical carcinogenesis","volume":"63","author":"Riley","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2019.08.013_bib20","first-page":"8173","article-title":"Comparative analysis of cervical cancer in women and in a human papillomavirus-transgenic mouse model: identification of minichromosome maintenance protein 7 as an informative biomarker for human cervical cancer","volume":"63","author":"Brake","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2019.08.013_bib21","doi-asserted-by":"crossref","first-page":"5656","DOI":"10.1158\/0008-5472.CAN-08-3711","article-title":"Human papillomavirus E7 oncoprotein overrides the tumor suppressor activity of p21Cip1 in cervical carcinogenesis","volume":"69","author":"Shin","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2019.08.013_bib22","doi-asserted-by":"crossref","first-page":"E3255","DOI":"10.1073\/pnas.1509322112","article-title":"Molecular transitions from papillomavirus infection to cervical precancer and cancer: role of stromal estrogen receptor signaling","volume":"112","author":"den Boon","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2019.08.013_bib23","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s12672-012-0125-7","article-title":"Requirement for stromal estrogen receptor alpha in cervical neoplasia","volume":"4","author":"Chung","year":"2013","journal-title":"Horm Cancer"},{"key":"10.1016\/j.ajpath.2019.08.013_bib24","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/path.5069","article-title":"Epithelial oestrogen receptor alpha is dispensable for the development of oestrogen-induced cervical neoplastic diseases","volume":"245","author":"Son","year":"2018","journal-title":"J Pathol"},{"key":"10.1016\/j.ajpath.2019.08.013_bib25","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.ajpath.2013.07.026","article-title":"Progesterone signaling inhibits cervical carcinogenesis in mice","volume":"183","author":"Yoo","year":"2013","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2019.08.013_bib26","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1128\/jvi.70.3.1873-1881.1996","article-title":"Squamous epithelial hyperplasia and carcinoma in mice transgenic for the human papillomavirus type 16 E7 oncogene","volume":"70","author":"Herber","year":"1996","journal-title":"J Virol"},{"key":"10.1016\/j.ajpath.2019.08.013_bib27","doi-asserted-by":"crossref","first-page":"5887","DOI":"10.1128\/JVI.73.7.5887-5893.1999","article-title":"The human papillomavirus type 16 E6 gene alone is sufficient to induce carcinomas in transgenic animals","volume":"73","author":"Song","year":"1999","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.ajpath.2019.08.013_bib28","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/dvg.20586","article-title":"A mouse model to dissect progesterone signaling in the female reproductive tract and mammary gland","volume":"48","author":"Fernandez-Valdivia","year":"2010","journal-title":"Genesis"},{"key":"10.1016\/j.ajpath.2019.08.013_bib29","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0925-4773(02)00292-7","article-title":"Efficient gene modulation in mouse epiblast using a Sox2Cre transgenic mouse strain","volume":"2","author":"Hayashi","year":"2002","journal-title":"Gene Expr Patterns"},{"key":"10.1016\/j.ajpath.2019.08.013_bib30","doi-asserted-by":"crossref","first-page":"19467","DOI":"10.1073\/pnas.0911436106","article-title":"Prevention and treatment of cervical cancer in mice using estrogen receptor antagonists","volume":"106","author":"Chung","year":"2009","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.ajpath.2019.08.013_bib31","doi-asserted-by":"crossref","first-page":"9393","DOI":"10.1158\/0008-5472.CAN-06-0984","article-title":"Critical roles for non-pRb targets of human papillomavirus type 16 E7 in cervical carcinogenesis","volume":"66","author":"Balsitis","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2019.08.013_bib32","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1158\/0008-5472.CAN-06-3344","article-title":"The human papillomavirus E6 oncogene dysregulates the cell cycle and contributes to cervical carcinogenesis through two independent activities","volume":"67","author":"Shai","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2019.08.013_bib33","doi-asserted-by":"crossref","first-page":"9928","DOI":"10.1158\/0008-5472.CAN-08-2051","article-title":"Requirement for estrogen receptor alpha in a mouse model for human papillomavirus-associated cervical cancer","volume":"68","author":"Chung","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2019.08.013_bib34","doi-asserted-by":"crossref","first-page":"17455","DOI":"10.18632\/oncotarget.8159","article-title":"Distinct functions and regulation of epithelial progesterone receptor in the mouse cervix, vagina, and uterus","volume":"7","author":"Mehta","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ajpath.2019.08.013_bib35","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0039-128X(95)00216-D","article-title":"Binding specificity of medroxyprogesterone acetate and proligestone for the progesterone and glucocorticoid receptor in the dog","volume":"61","author":"Selman","year":"1996","journal-title":"Steroids"},{"key":"10.1016\/j.ajpath.2019.08.013_bib36","doi-asserted-by":"crossref","first-page":"a1284","DOI":"10.1136\/bmj.a1284","article-title":"Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis","volume":"337","author":"Arbyn","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.ajpath.2019.08.013_bib37","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/LGT.0b013e3181ac05e9","article-title":"Incidence and costs of cervical intraepithelial neoplasia in a US commercially insured population","volume":"14","author":"Henk","year":"2010","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.ajpath.2019.08.013_bib38","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1002\/ijc.32195","article-title":"Recent increase in incidence of cervical precancerous lesions in Norway: nationwide study from 1992 to 2016","volume":"145","author":"Orumaa","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajpath.2019.08.013_bib39","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1200\/JCO.1999.17.6.1736","article-title":"Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology Group","volume":"17","author":"Thigpen","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajpath.2019.08.013_bib40","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3949\/ccjm.84a.15140","article-title":"ERAAs for menopause treatment: welcome the \u2018designer estrogens'","volume":"84","author":"Hirsch","year":"2017","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.ajpath.2019.08.013_bib41","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.maturitas.2004.12.007","article-title":"Relief of vasomotor symptoms and vaginal atrophy with three doses of conjugated estrogens and medroxyprogesterone acetate in postmenopausal Asian women from 11 countries: the Pan-Asia menopause (PAM) study","volume":"52","author":"Tan","year":"2005","journal-title":"Maturitas"},{"key":"10.1016\/j.ajpath.2019.08.013_bib42","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0015-0282(01)01791-5","article-title":"Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate","volume":"75","author":"Utian","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajpath.2019.08.013_bib43","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1126\/science.1197454","article-title":"The antiproliferative action of progesterone in uterine epithelium is mediated by Hand2","volume":"331","author":"Li","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2019.08.013_bib44","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1530\/REP-06-0302","article-title":"Circulating hormones and estrous stage predict cellular and stromal remodeling in murine uterus","volume":"133","author":"Wood","year":"2007","journal-title":"Reproduction"},{"key":"10.1016\/j.ajpath.2019.08.013_bib45","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.tem.2015.06.004","article-title":"Targeting female hormone receptors as cervical cancer therapy","volume":"26","author":"Chung","year":"2015","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.ajpath.2019.08.013_bib46","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0360-3016(00)00495-8","article-title":"Progesterone receptor is a favorable prognostic factor of radiation therapy for adenocarcinoma of the uterine cervix","volume":"47","author":"Suzuki","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ajpath.2019.08.013_bib47","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0090-8258(83)90113-0","article-title":"Estrogen and progesterone receptor sites in malignancies of the uterine cervix, vagina, and vulva","volume":"15","author":"Ford","year":"1983","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajpath.2019.08.013_bib48","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/(SICI)1097-0142(19970201)79:3<505::AID-CNCR12>3.0.CO;2-7","article-title":"Adenocarcinoma of the cervix. Expression and clinical significance of estrogen and progesterone receptors","volume":"79","author":"Fujiwara","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.ajpath.2019.08.013_bib49","first-page":"153","article-title":"Estrogen and progesterone receptor expression in HPV-positive and HPV-negative cervical carcinomas","volume":"26","author":"Kwasniewska","year":"2011","journal-title":"Oncol Rep"},{"key":"10.1016\/j.ajpath.2019.08.013_bib50","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1136\/ijgc-00009577-200409000-00026","article-title":"Estrogen receptor, progesterone receptor, and bcl-2 are markers with prognostic significance in CIN III","volume":"14","author":"Fonseca-Moutinho","year":"2004","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ajpath.2019.08.013_bib51","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.18632\/oncotarget.13676","article-title":"Recurrence of cervical cancer and its resistance to progestin therapy in a mouse model","volume":"8","author":"Mehta","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ajpath.2019.08.013_bib52","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/0002-9378(88)90075-0","article-title":"Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium","volume":"158","author":"Ehrlich","year":"1988","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajpath.2019.08.013_bib53","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00404-018-4928-9","article-title":"Glucocorticoid receptor in cervical cancer: an immunohistochemical analysis","volume":"299","author":"Kost","year":"2019","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ajpath.2019.08.013_bib54","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/PGP.0b013e318160c599","article-title":"Androgen receptor expression in cervical intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix","volume":"27","author":"Noel","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.ajpath.2019.08.013_bib55","doi-asserted-by":"crossref","first-page":"884","DOI":"10.2353\/ajpath.2010.091166","article-title":"Loss of estrogen receptor 1 enhances cervical cancer invasion","volume":"177","author":"Zhai","year":"2010","journal-title":"Am J Pathol"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944019307175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944019307175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T16:35:09Z","timestamp":1757694909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944019307175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":55,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S0002944019307175"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2019.08.013","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medroxyprogesterone Acetate Prevention of Cervical Cancer through Progesterone Receptor in a Human Papillomavirus Transgenic Mouse Model","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2019.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}